Publications by authors named "David C Howe"

Claim this Profile
P
Paradigm shifts caused by the COVID-19 pandemic.
David C Howe, Rahul S Chauhan, Andrew T Soderberg, M Ronald Buckley

Organ Dyn· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The translational efficacy of a nonsteroidal progesterone receptor antagonist, 4-[3-cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on endometrial growth in macaque and human.
David C Howe, Natalie M Mount, Kirsty Bess, Amy Brown, Peter Bungay

J Pharmacol Exp Ther· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and clinical pharmacokinetics of PF-02413873, a nonsteroidal progesterone receptor antagonist.
Peter J Bungay, Sarah Tweedy, David C Howe, Karl R Gibson, Hannah M Jones

Drug Metab Dispos· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observing three-dimensional human microvascular and myogenic architecture using conventional fluorescence microscopy.
Shabaz A Hamid, Louise E A Ferguson, C Jay McGavigan, David C Howe, Steven Campbell

Micron· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualisation of morphological changes in living intact human microvessels using confocal microscopy.
Shabaz A Hamid, David C Howe, Steven Campbell, Craig J Daly

Microvasc Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep.
Judit Molnar, David C Howe, Mark J M Nijland, Peter W Nathanielsz

J Physiol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep.
Judit Molnar, Mark J M Nijland, David C Howe, Peter W Nathanielsz

Am J Physiol Regul Integr Comp Physiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urocortin: a mechanism for the sustained activation of the HPA axis in the late-gestation ovine fetus?
Alison C Holloway, David C Howe, Gabriel Chan, Vicki L Clifton, Roger Smith

Am J Physiol Endocrinol Metab· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis